1.0
Sep 18, 2024
Anonymous employee
Current employee, more than 3 years
Recommend
CEO approval
Business outlook
Pros
Meh. The McDonald's of Pharma.
Cons
Not the Wendy's of Pharma. Sticks to the status quo, even for innovation which slaps them in the face with something that could lead to a wide range of ROI and growth. Retrofits innovative ideas into policy and discussions never to actually innovate with a growth mindset, but with a "this is how we do it and its always been" idealism. Too many "pick me" "look at me" workers and not enough collaboration to actually learn and feed off of innovative ideas.